HIGHLIGHTS
- who: Roza Chaireti and Hareth Nahi from the Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden Department of Hematology, Karolinska University Hospital, Stockholm, Sweden have published the article: Risk Factors and Risk Stratification of Thromboembolic Risk in Patients with Multiple Myeloma, in the Journal: Hemato 2022, 3, 518-526. of /2022/
- what: The MELISSE study aimed to evaluate the thrombotic risk in a cohort of >500 patients with MM treated with IMiDs, of which the majority received platelet inhibitors as thromboprophylaxis.
- how: Thrombin generation (TG) was measured by the calibrated automated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.